These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31127619)

  • 1. Immunity and hypertension: New targets to lighten the pressure.
    Vinh A; Drummond GR; Sobey CG
    Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes as immune targets in arterial hypertension.
    Wenzel P
    Br J Pharmacol; 2019 Jun; 176(12):1966-1977. PubMed ID: 29885051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt, inflammation, IL-17 and hypertension.
    Wenzel UO; Bode M; Kurts C; Ehmke H
    Br J Pharmacol; 2019 Jun; 176(12):1853-1863. PubMed ID: 29767465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of hypertension in autoimmune rheumatic diseases.
    Taylor EB; Wolf VL; Dent E; Ryan MJ
    Br J Pharmacol; 2019 Jun; 176(12):1897-1913. PubMed ID: 30714094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell trafficking, lymphatics and hypertension.
    Balasubbramanian D; Lopez Gelston CA; Rutkowski JM; Mitchell BM
    Br J Pharmacol; 2019 Jun; 176(12):1978-1988. PubMed ID: 29797446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inflammation to reduce cardiovascular disease risk.
    Maffia P; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.
    Carnagarin R; Matthews V; Zaldivia MTK; Peter K; Schlaich MP
    Br J Pharmacol; 2019 Jun; 176(12):1839-1852. PubMed ID: 30129037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of autoimmune reactivity induced by heat shock protein 70 in the pathogenesis of essential hypertension.
    Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    Br J Pharmacol; 2019 Jun; 176(12):1829-1838. PubMed ID: 29679484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.
    Alexander MR; Norlander AE; Elijovich F; Atreya RV; Gaye A; Gnecco JS; Laffer CL; Galindo CL; Madhur MS
    Br J Pharmacol; 2019 Jun; 176(12):2015-2027. PubMed ID: 29774543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immune cells in hypertension.
    Caillon A; Paradis P; Schiffrin EL
    Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?
    Taylor LE; Ramirez LA; Musall JB; Sullivan JC
    Br J Pharmacol; 2019 Nov; 176(21):4226-4242. PubMed ID: 31271650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: a new treatment for an old disease? Targeting the immune system.
    Bomfim GF; Cau SBA; Bruno AS; Fedoce AG; Carneiro FS
    Br J Pharmacol; 2019 Jun; 176(12):2028-2048. PubMed ID: 29969833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.
    Don-Doncow N; Zhang Y; Matuskova H; Meissner A
    Br J Pharmacol; 2019 Jun; 176(12):1989-2001. PubMed ID: 29856066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.
    Czesnikiewicz-Guzik M; Nosalski R; Mikolajczyk TP; Vidler F; Dohnal T; Dembowska E; Graham D; Harrison DG; Guzik TJ
    Br J Pharmacol; 2019 Jun; 176(12):1922-1931. PubMed ID: 30414380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
    Welsh P; Grassia G; Botha S; Sattar N; Maffia P
    Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the matrix.
    Whiteford JR; Arokiasamy S; De Rossi G
    Br J Pharmacol; 2019 Jan; 176(1):3-4. PubMed ID: 30525194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoceptors-New roles for old players.
    Michel MC; Bond RA; Summers RJ
    Br J Pharmacol; 2019 Jul; 176(14):2339-2342. PubMed ID: 31240712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and their actions: An update.
    Alexander SPH; Molina-Holgado F
    Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide is not just blowing in the wind.
    Ignarro LJ
    Br J Pharmacol; 2019 Jan; 176(2):131-134. PubMed ID: 30556130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mediators: a causal link to hypertension during preeclampsia.
    Cornelius DC; Cottrell J; Amaral LM; LaMarca B
    Br J Pharmacol; 2019 Jun; 176(12):1914-1921. PubMed ID: 30095157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.